Conditional survival nomogram for patients with colon mucinous adenocarcinoma to predict prognosis: a dynamic survival analysis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Conditional survival offers dynamic survival probabilities for colon mucinous adenocarcinoma (MAC) patients, improving predictions for advanced stages. New nomograms predict conditional disease-free survival (DFS) and overall survival (OS) based on years already survived.
Area Of Science
- Oncology
- Biostatistics
- Cancer Research
Background
- Colon mucinous adenocarcinoma (MAC) survival rates require dynamic assessment beyond initial diagnosis.
- Traditional survival analysis may not accurately reflect long-term prognosis for individual patients.
- Conditional survival provides a more personalized and adaptive approach to estimating patient outcomes.
Purpose Of The Study
- To assess conditional survival (CS) for colon MAC patients.
- To develop nomograms for predicting conditional disease-free survival (DFS) and overall survival (OS).
- To identify prognostic factors influencing conditional survival in colon MAC.
Main Methods
- Survival analysis using the conditional survival formula: CS (y|x) = S(x+y)/S(x).
- Cox regression analyses to identify significant prognostic factors.
- Construction of nomograms to predict 5-year conditional DFS and OS based on years survived post-surgery.
Main Results
- The 5-year DFS was 67% and 5-year OS was 73% post-surgery.
- Conditional survival probabilities increased significantly with each additional year survived (e.g., 5-year OS rose from 73% to 92% after 4 years).
- Prognostic factors like pT stage, pN stage, and lymphovascular invasion impacted DFS and OS; conditional survival benefits were more pronounced in advanced stages.
Conclusions
- Conditional survival provides a dynamic and more accurate survival probability for colon MAC patients.
- The developed nomograms effectively predict conditional DFS and OS, particularly for advanced stage patients.
- Incorporating time already survived enhances the precision of survival prediction in colon MAC.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...